CUE - CIK 0001645460
Cue Biopharma, Inc. has filed 496 documents with the SEC between 2015 and 2026. The most frequent type is insider trade (196 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Prospectus supplement | 424B5 | 2024-09-27 | - |
| Prospectus supplement | 424B5 | 2024-09-26 | - |
| Proxy statement | DEF 14A | 2024-09-10 | 2024-10-08 |
| New insider ownership | 3 | 2024-09-05 | 2024-09-03 |
| Insider trade | 4 | 2024-09-05 | 2024-09-03 |
| Major company event | 8-K | 2024-09-03 | 2024-08-28 |
| PRE 14A | - | 2024-08-28 | 2024-10-08 |
| Major company event | 8-K | 2024-08-16 | 2024-08-15 |
| Quarterly report | 10-Q | 2024-08-14 | 2024-06-30 |
| Major company event | 8-K | 2024-07-25 | 2024-07-24 |
| Major company event | 8-K | 2024-06-07 | 2024-06-05 |
| Insider trade | 4 | 2024-06-07 | 2024-06-05 |
| Insider trade | 4 | 2024-06-07 | 2024-06-05 |
| Insider trade | 4 | 2024-06-07 | 2024-06-05 |
| Insider trade | 4 | 2024-06-07 | 2024-06-05 |
| New insider ownership | 3 | 2024-06-07 | 2024-06-05 |
| Insider trade | 4 | 2024-06-07 | 2024-06-05 |
| Proxy materials | DEFA14A | 2024-05-24 | - |
| Major company event | 8-K | 2024-05-09 | 2024-05-09 |
| Quarterly report | 10-Q | 2024-05-09 | 2024-03-31 |
| Proxy statement | DEF 14A | 2024-04-26 | 2024-06-05 |
| Proxy materials | DEFA14A | 2024-04-26 | - |
| Annual report to shareholders | ARS | 2024-04-26 | 2023-12-31 |
| Employee stock plan | S-8 | 2024-03-28 | - |
| Annual report | 10-K | 2024-03-28 | 2023-12-31 |
| Passive ownership stake | SC 13G | 2024-03-11 | - |
| Insider trade | 4 | 2024-03-08 | 2024-03-06 |
| Insider trade | 4 | 2024-03-08 | 2024-03-06 |
| Insider trade | 4 | 2024-03-08 | 2024-03-06 |
| Insider trade | 4 | 2024-03-08 | 2024-03-06 |
| Insider trade | 4 | 2024-03-08 | 2024-03-06 |
| Insider trade | 4 | 2024-02-22 | 2024-02-20 |
| Passive ownership stake | SC 13G | 2024-01-31 | - |
| Insider trade | 4 | 2024-01-04 | 2024-01-02 |
| Insider trade | 4 | 2024-01-04 | 2024-01-02 |
| Insider trade | 4 | 2024-01-04 | 2024-01-02 |
| Insider trade | 4 | 2024-01-04 | 2024-01-02 |
| Insider trade | 4 | 2024-01-04 | 2024-01-02 |
| Quarterly report | 10-Q | 2023-11-03 | 2023-09-30 |
| Major company event | 8-K | 2023-09-14 | 2023-09-12 |
| Insider trade | 4 | 2023-08-29 | 2023-08-25 |
| Insider trade | 4 | 2023-08-16 | 2023-08-14 |
| Quarterly report | 10-Q | 2023-08-08 | 2023-06-30 |
| Insider trade | 4 | 2023-07-25 | 2023-07-21 |
| Insider trade | 4 | 2023-07-25 | 2023-07-21 |
| Insider trade | 4 | 2023-07-25 | 2023-07-21 |
| Insider trade | 4 | 2023-07-25 | 2023-07-21 |
| Insider trade | 4 | 2023-07-25 | 2023-07-21 |
| Major company event | 8-K | 2023-06-09 | 2023-06-07 |
| EFFECT | - | 2023-05-26 | - |